# Evaluate the Safety and Efficacy of CAR-T Cells in the Treatment of R/R Neuromyelitis Optica

> **NCT05828212** · PHASE1 · COMPLETED · sponsor: **Zhejiang University** · enrollment: 9 (actual)

## Conditions studied

- Neuromyelitis Optica

## Interventions

- **DRUG:** CAR-T cells injection

## Key facts

- **NCT ID:** NCT05828212
- **Lead sponsor:** Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-05-15
- **Primary completion:** 2025-07-30
- **Final completion:** 2025-07-30
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2025-08-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05828212

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05828212, "Evaluate the Safety and Efficacy of CAR-T Cells in the Treatment of R/R Neuromyelitis Optica". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05828212. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*